Title of article
Seroepidemiology of Human T-cell Lymphotropic Virus 1 Infection in Hemodialysis Patients Should We be Concerned About it?
Author/Authors
Ghaffari, Javad mazandaran university of medical sciences - Department of Immunology, ايران , Ebrahimi, Mahbobeh mazandaran university of medical sciences - Molecular and Cellular Biology Research Center, Faculty of Medicine, ايران , Makhlough, Atieh mazandaran university of medical sciences - Department of Internal Medicine, Division of Nephrology, ايران , Mohammadjafari, Hamid mazandaran university of medical sciences - Department of Pediatrics, Division of Pediatric Nephrology, ايران , Nazari, Zeinab mazandaran university of medical sciences - Departments of Oncologyand Gynecology, ايران
From page
187
To page
190
Abstract
Human T-cell lymphotropic virus 1 (HTLV1) is a lymphotropic virus which can be transmitted through unprotected sexual activity, breast feeding, and blood transfusion. Although most of HTLV1-infected individuals remain asymptomatic carriers, 1% to 5% and 3% to 5% develop adult T-cell leukemia and HTLV1-associated myelopathy/tropical spastic paraparesis, respectively.
Keywords
human T , cell lymphotropic virus 1 , seroepidemiologic studies , hemodialysis
Journal title
Iranian Journal of Kidney Diseases (IJKD)
Journal title
Iranian Journal of Kidney Diseases (IJKD)
Record number
2670012
Link To Document